共 50 条
- [41] Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohortANNALS OF ONCOLOGY, 2022, 33 (07) : S680 - S681Kuboki, Y.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, Japan Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanYaeger, R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanFakih, M. G.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanStrickler, J. H.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Dept Med, Med Ctr, Durham, NC USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanMasuishi, T.论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Clin Oncol Dept, Nagoya, Aichi, Japan Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanKim, E. J.论文数: 0 引用数: 0 h-index: 0机构: UC Davis Comprehens Canc Ctr, Hematol Oncol Internal Med, Sacramento, CA USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanBestvina, C. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanLanger, C. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Hematol Oncol, Philadelphia, PA USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanKrauss, J. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Hematol Oncol Internal Med, Ann Arbor, MI USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanPuri, S.论文数: 0 引用数: 0 h-index: 0机构: Huntsman Canc Inst, Med Hematol & Oncol, Salt Lake City, UT USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanCardona, P.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Clin Pharmacol Modeling & Simulat, Thousand Oaks, CA USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanChan, E.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Res & Dev, Thousand Oaks, CA USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanTran, Q.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Res & Dev, Thousand Oaks, CA USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, JapanHong, D. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX USA Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, Japan
- [42] Sotorasib in KRAS p.G12C mutated advanced NSCLC: Real-word data from the Italian Expanded Access ProgramANNALS OF ONCOLOGY, 2023, 34Reale, M. L.论文数: 0 引用数: 0 h-index: 0机构: Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyPassiglia, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Turin, Dept Oncol, AOU San Luigi Gonzaga, Orbassano, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyBrambilla, M.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Med Sch, Padua, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyPasello, G.论文数: 0 引用数: 0 h-index: 0机构: Veneto Inst Oncol IOV IRCCS, Med Oncol 2, Padua, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyMinuti, G.论文数: 0 引用数: 0 h-index: 0机构: Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyBulotta, A.论文数: 0 引用数: 0 h-index: 0机构: IRCCS Osped San Raffaele, Dept Oncol, Milan, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyPizzutilo, P.论文数: 0 引用数: 0 h-index: 0机构: Ist Tumori Giovanni Paolo II, Med Thorac Oncol Unit, Bari, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalySini, C.论文数: 0 引用数: 0 h-index: 0机构: ATS Sardegna ASSL Olbia, Med Oncol, Osped Giovanni Paolo 2, Olbia, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyCosta, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Udine, Santa Maria Misericordia Hosp, Dipartimento Area Medica DAME, Udine, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyRoca, E.论文数: 0 引用数: 0 h-index: 0机构: P Pederzoli Hosp, Lung Unit, Thorac Oncol, Peschiera del Garda, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyBria, E.论文数: 0 引用数: 0 h-index: 0机构: Fdn Policlin Univ Agostino Gemelli IRCCS, Translat Med & Surg Dept, Rome, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, Italy论文数: 引用数: h-index:机构:Genova, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Genoa, Lung Canc Unit, Genoa, Italy Osped Policlin San Martino IRCCS, DiMI, Genoa, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyMetro, G.论文数: 0 引用数: 0 h-index: 0机构: Osped S Maria Misericordia, Dept Med Oncol, Perugia, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyCitarella, F.论文数: 0 引用数: 0 h-index: 0机构: Policlin Univ, Dept Oncol, Campus Bio Med, Rome, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyBordi, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Parma, Med Oncol Unit, Parma, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyRusso, A.论文数: 0 引用数: 0 h-index: 0机构: Ctr Oncol Osped Papardo, Med Oncol Unit, Messina, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyChiari, R.论文数: 0 引用数: 0 h-index: 0机构: UOC Oncol, AST Pesaro Urbino, Pesaro, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyAndrikou, K.论文数: 0 引用数: 0 h-index: 0机构: Ist Romagnolo Tumori Dino Amadori IRST, Dept Med Oncol, Ist Ricovero & Cura Carattere Sci IRCCS, Meldola, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, ItalyNovello, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Turin, Dept Oncol, AOU San Luigi Gonzaga, Orbassano, Italy Vito Fazzi Hosp ASL Lecce, Dept Oncol, Lecce, Italy
- [43] MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) IN PREVIOUSLY TREATED KRAS G12C-MUTATED ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (A/MNSCLC): ADAGRASIB VERSUS SOTORASIBVALUE IN HEALTH, 2023, 26 (12) : S31 - S31Bouwmeester, W.论文数: 0 引用数: 0 h-index: 0机构: PRECISIONheor, London, England PRECISIONheor, London, EnglandLaurie, M.论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, San Diego, CA USA PRECISIONheor, London, EnglandKorytowsky, B.论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, San Diego, CA USA PRECISIONheor, London, EnglandGrevinga, M.论文数: 0 引用数: 0 h-index: 0机构: PRECISIONheor, London, England PRECISIONheor, London, EnglandQian, C.论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, San Diego, CA USA PRECISIONheor, London, EnglandBerardi, A.论文数: 0 引用数: 0 h-index: 0机构: PRECISIONheor, London, England PRECISIONheor, London, EnglandGao, S.论文数: 0 引用数: 0 h-index: 0机构: Mirati Therapeut, San Diego, CA USA PRECISIONheor, London, England论文数: 引用数: h-index:机构:
- [44] A Case Series of Patients With Kras KRAS G12C Mutation Treated With Sotorasib - Croatian ExperienceJOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S426 - S426Seiwerth, F.论文数: 0 引用数: 0 h-index: 0机构: UMC Zagreb, Zagreb, Croatia UMC Zagreb, Zagreb, CroatiaBitar, L.论文数: 0 引用数: 0 h-index: 0机构: UMC Zagreb, Zagreb, Croatia UMC Zagreb, Zagreb, CroatiaFranolic, I. Lukic论文数: 0 引用数: 0 h-index: 0机构: UMC Zagreb, Zagreb, Croatia UMC Zagreb, Zagreb, CroatiaSajnic, A.论文数: 0 引用数: 0 h-index: 0机构: UMC Zagreb, Clin Resp Dis Jordanovac, Zaggreb, Croatia UMC Zagreb, Zagreb, CroatiaJakopovic, M.论文数: 0 引用数: 0 h-index: 0机构: UMC Zagreb, Zagreb, Croatia UMC Zagreb, Zagreb, CroatiaSamarzija, M.论文数: 0 引用数: 0 h-index: 0机构: UMC Zagreb, Zagreb, Croatia UMC Zagreb, Zagreb, Croatia
- [45] Clinical validation of plasma cell-free DNA (cfDNA) sequencing in the phase 2 trial of sotorasib in patients (pts) with KRAS p.G12C mutated NSCLC.CANCER RESEARCH, 2021, 81 (13)Bauml, Joshua M.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA USA Univ Penn, Philadelphia, PA USALi, Bob T.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY USA Univ Penn, Philadelphia, PA USAVelcheti, Vamsidhar论文数: 0 引用数: 0 h-index: 0机构: NYU Langone Laura & Isaac Perlmutter Canc Ctr, New York, NY USA Univ Penn, Philadelphia, PA USA论文数: 引用数: h-index:机构:Fontecedro, Alessandra Curioni论文数: 0 引用数: 0 h-index: 0机构: Univ Zurich Hosp, Zurich, Switzerland Univ Penn, Philadelphia, PA USADooms, Christophe论文数: 0 引用数: 0 h-index: 0机构: Leuven Univ Hosp, Leuven, Belgium Univ Penn, Philadelphia, PA USATakahashi, Toshiaki论文数: 0 引用数: 0 h-index: 0机构: Shizuoka Canc Ctr, Shizuoka, Japan Univ Penn, Philadelphia, PA USADuda, Andrew W.论文数: 0 引用数: 0 h-index: 0机构: Guardant Hlth, Redwood City, CA USA Univ Penn, Philadelphia, PA USAOdegaard, Justin论文数: 0 引用数: 0 h-index: 0机构: Guardant Hlth, Redwood City, CA USA Univ Penn, Philadelphia, PA USACruz-Guilloty, Fernando论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Univ Penn, Philadelphia, PA USAJin, Liming论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Univ Penn, Philadelphia, PA USAZhang, Ying论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Univ Penn, Philadelphia, PA USASkoulidis, Ferdinandos论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Univ Penn, Philadelphia, PA USA
- [46] Sotorasib in Advanced KRAS p.G12C-Mutated NSCLC with Treated or Untreated Brain Metastases: Safety and Efficacy Data from the Global Expanded Access Program (EAP)JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E17 - E17Awad, M. M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Dana Farber Canc Inst, Boston, MA USAPelizzari, G.论文数: 0 引用数: 0 h-index: 0机构: Azienda Sanitaria Univ Friuli Cent, Dipartimento Oncol Udine, Udine, Italy Dana Farber Canc Inst, Boston, MA USAStevenson, J.论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH USA Dana Farber Canc Inst, Boston, MA USAMajem, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Creu i Sant Pau, Dept Med Oncol, Barcelona, Spain Dana Farber Canc Inst, Boston, MA USAFerreira, C. Gil论文数: 0 引用数: 0 h-index: 0机构: Oncoclin Inst Res & Educ, Dept Educ & Res, Rio De Janeiro, Brazil Dana Farber Canc Inst, Boston, MA USAPetty, W.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Univ, Dept Hematol & Oncol, Sch Med, Winston Salem, NC USA Dana Farber Canc Inst, Boston, MA USAArriola, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Mar Parc Salut Mar, Dept Med Oncol, Barcelona, Spain Dana Farber Canc Inst, Boston, MA USADe Castro, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain Dana Farber Canc Inst, Boston, MA USAMorbeck, I.论文数: 0 引用数: 0 h-index: 0机构: Hosp Sirio Libanes, Ctr Oncol, Ctr Oncol Asa Sul, Brasilia, DF, Brazil Dana Farber Canc Inst, Boston, MA USABauman, J.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Dept Hematol Oncol, Main Campus, Philadelphia, PA USA Dana Farber Canc Inst, Boston, MA USAToschi, L.论文数: 0 引用数: 0 h-index: 0机构: Ist Clin Humanitas, Dept Med Oncol, Rozzano, Italy Dana Farber Canc Inst, Boston, MA USAZer, A.论文数: 0 引用数: 0 h-index: 0机构: Davidoff Canc Ctr, Rabin Med Ctr, Thorac Canc Serv, Petah Tiqwa, Israel Dana Farber Canc Inst, Boston, MA USAMetro, G.论文数: 0 引用数: 0 h-index: 0机构: Osped S Maria Misericordia, Dept Med Oncol, Perugia, Italy Dana Farber Canc Inst, Boston, MA USAKalmadi, S.论文数: 0 引用数: 0 h-index: 0机构: Ironwood Canc & Res Ctr, Dept Hematol & Med Oncol, Chandler, AZ USA Dana Farber Canc Inst, Boston, MA USAAzkarate, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Son Espases, Dept Med Oncol, Palma de Mallorca, Spain Dana Farber Canc Inst, Boston, MA USAXia, C.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Dana Farber Canc Inst, Boston, MA USAMeloni, A.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Dana Farber Canc Inst, Boston, MA USAObiozor, C.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Dana Farber Canc Inst, Boston, MA USAHsu, H.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Dana Farber Canc Inst, Boston, MA USAVarrieur, T.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Dana Farber Canc Inst, Boston, MA USAArdito-Abraham, C.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Dana Farber Canc Inst, Boston, MA USAMaimon, N.论文数: 0 引用数: 0 h-index: 0机构: Sackler Sch Med, Div Oncol, Meir Med Ctr, Oncol Serv, Rishon Leziyyon, Israel Dana Farber Canc Inst, Boston, MA USANovello, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Torino Orbassano, Dept Oncol, Orbassano, Italy Dana Farber Canc Inst, Boston, MA USA
- [47] Sotorasib versus pembrolizumab in combination with platinum doublet chemotherapy as first-line treatment for metastatic or locally advanced, PD-L1 negative, KRAS G12C-mutated NSCLC (CodeBreaK 202)JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Barlesi, Fabrice论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceFelip, Enriqueta论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FrancePopat, Sanjay论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceSolomon, Benjamin J.论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceWolf, Juergen论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceLi, Bob T.论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceWu, Yi-Long论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceKerr, Keith论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceAkamatsu, Hiroaki论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceCamidge, David Ross论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceGupta, Ravi G.论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceMeloni, Alison论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceDai, Tian论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, FranceBorghaei, Hossein论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Villejuif, France
- [48] Rapid Response to Sotorasib of a Patient With KRAS G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case ReportJTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (01):Kunimasa, Kei论文数: 0 引用数: 0 h-index: 0机构: Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan Osaka Int Canc Inst, Dept Thorac Oncol, 3-1-69 Otemae Chuoku, Osaka, Osaka 5418567, Japan Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, JapanTamiya, Motohiro论文数: 0 引用数: 0 h-index: 0机构: Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, JapanInoue, Takako论文数: 0 引用数: 0 h-index: 0机构: Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, JapanKawamura, Takahisa论文数: 0 引用数: 0 h-index: 0机构: Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, JapanNishino, Kazumi论文数: 0 引用数: 0 h-index: 0机构: Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan
- [49] Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12CNEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (23): : 2125 - 2139Fakih, Marwan G.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA City Hope Comprehens Canc Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USASalvatore, Lisa论文数: 0 引用数: 0 h-index: 0机构: Univ Cattolica Sacro Cuore, Oncol Med, Rome, Italy Fdn Policlin Univ Agostino Gemelli IRCCS, Comprehens Canc Ctr, Oncol Med, Rome, Italy City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAEsaki, Taito论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAModest, Dominik P.论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Med Dept Hematol, Oncol & Tumor Immunol, Berlin, Germany City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USALopez-Bravo, David P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Creu i St Pau, Dept Med Oncol, Barcelona, Spain City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USATaieb, Julien论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Cite, Hop Europeen Georges Pompidou, Canc Res Personalized Med Comprehens Canc Ctr, Dept Gastroenterol & Digest Oncol,Site Rech Integ, Paris, France City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAKaramouzis, Michalis V.论文数: 0 引用数: 0 h-index: 0机构: Natl & Kapodistrian Univ Athens, Sch Med, Dept Biol Chem, Athens, Greece City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USARuiz-Garcia, Erika论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Cancerol, Gastrointestinal Oncol Dept, Mexico City, Mexico Inst Nacl Cancerol, Translat Med Lab, Mexico City, Mexico City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAKim, Tae-Won论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Oncol Dept, Seoul, South Korea City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAKuboki, Yasutoshi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, Japan City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAMeriggi, Fausto论文数: 0 引用数: 0 h-index: 0机构: Fdn Poliambulanza Ist Osped, Oncol Dept, Brescia, Italy City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USACunningham, David论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Med Dept, London, England City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAYeh, Kun-Huei论文数: 0 引用数: 0 h-index: 0机构: Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei, Taiwan City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAChan, Emily论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USAChao, Joseph论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USASaportas, Yaneth论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USATran, Qui论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA论文数: 引用数: h-index:机构:Pietrantonio, Filippo论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Med Oncol Dept, Milan, Italy City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA
- [50] Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutationLUNG CANCER, 2024, 196Waterhouse, David M.论文数: 0 引用数: 0 h-index: 0机构: Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USA Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USARothschild, Sacha论文数: 0 引用数: 0 h-index: 0机构: Univ Basel, Dept Biomed, Basel, Switzerland Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USADooms, Christophe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp KU Leuven, Dept Resp Dis, Leuven, Belgium Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAMennecier, Bertrand论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Strasbourg, Pulmonol Unit, Strasbourg, France Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USABozorgmehr, Farastuk论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany DKFZ & Heidelberg Univ Hosp, Natl Ctr Tumor Dis NCT, NCT Heidelberg, Heidelberg, Germany German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC H, Heidelberg, Germany Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAMajem, Margarita论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Creu & Sant Pau, Dept Med Oncol, Serv Oncol Med, Barcelona, Spain Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAHeuvel, Michel H. van den论文数: 0 引用数: 0 h-index: 0机构: Radboud Univ Nijmegen, Med Ctr, Dept Resp Dis, Nijmegen, Gelderland, Netherlands Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USALinardou, Helena论文数: 0 引用数: 0 h-index: 0机构: Metropolitan Hosp, Oncol Dept 4, Athens, Greece Metropolitan Hosp, Comprehens Clin Trials Ctr, Athens, Greece Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USACho, Byoung Chul论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Div Med Oncol,Coll Med, Seoul, South Korea Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USARoberts-Thomson, Rachel论文数: 0 引用数: 0 h-index: 0机构: Queen Elizabeth Hosp, Dept Med Oncol, Woodville, South Africa Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USA论文数: 引用数: h-index:机构:Blais, Normand论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USASchvartsman, Gustavo论文数: 0 引用数: 0 h-index: 0机构: Hosp Israelita Albert Einstein, Ctr Oncol & Hematol Einstein Familia Dayan Daycova, Sao Paulo, Brazil Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAHansen, Karin Holmskov论文数: 0 引用数: 0 h-index: 0机构: Odense Univ Hosp, Dept Oncol, Odense, Denmark Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAChmielewska, Izabela论文数: 0 引用数: 0 h-index: 0机构: Med Univ Lublin, Dept Pneumonol Oncol & Allergol, Lublin, Poland Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAForster, Martin D.论文数: 0 引用数: 0 h-index: 0机构: UCL Canc Inst, Sarah Cannon Res Inst, London, England Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAGiannopoulou, Christina论文数: 0 引用数: 0 h-index: 0机构: Amgen Europe GmbH, Rotkreuz, Switzerland Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAStollenwerk, Bjorn论文数: 0 引用数: 0 h-index: 0机构: Amgen Europe GmbH, Rotkreuz, Switzerland Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAObiozor, Cynthia C.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USAWang, Yang论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA USA Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USANovello, Silvia论文数: 0 引用数: 0 h-index: 0机构: Univ Torino, San Luigi Hosp Orbassano, Dept Oncol, Turin, Italy Oncol Hematol Care OHC SCRI Res, Cincinnati, OH 45226 USA